Faraz Ali is CEO at Tenaya Therapeutics, Inc. (TNYA). They have made 10 open-market trades across 1 company since 2023, most recently 2026-09-10.
CIK 0001667937
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TNYA | 539,782 | $201K |
Shares reported on the most recent Form 4, priced at the 2026-09-11 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNYA | SELL | 2026-08-17 | 2026-08-17 | $0.71 | $16K | +0.7% | -5.2% | — |
| TNYA | SELL | 2026-05-18 | 2026-05-19 | $0.79 | $3K | +10.0% | -8.9% | -11.8% |
| TNYA | SELL | 2026-02-17 | 2026-02-17 | $0.64 | $10K | -12.2% | +24.5% | +23.8% |
| TNYA | SELL | 2025-11-17 | 2025-11-17 | $1.33 | $4K | +12.0% | -46.6% | -49.5% |
| TNYA | SELL | 2025-08-18 | 2025-08-18 | $1.25 | $18K | -12.4% | -5.4% | -2.3% |
| TNYA | SELL | 2025-05-16 | 2025-05-16 | $0.44 | $1K | +1.1% | +41.6% | +115.4% |
| TNYA | SELL | 2025-03-10 | 2025-03-10 | $0.54 | $5K | +26.5% | -12.7% | +32.3% |
| TNYA | SELL | 2024-08-16 | 2024-08-16 | $2.89 | $28K | -8.0% | -30.9% | -29.9% |
| TNYA | SELL | 2024-02-16 | 2024-02-16 | $5.86 | $37K | -3.9% | -22.1% | -31.3% |
| TNYA | SELL | 2023-08-16 | 2023-08-18 | $3.81 | $21K | +4.9% | -25.0% | -53.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.